Cidofovir: The antiviral powerhouse designed to stop viral DNA replication in its tracks
In short: Discovered in Prague by Antonín Holý, cidofovir is a potent antiviral medication that targets viral DNA polymerases. While primarily approved for treating cytomegalovirus retinitis in AIDS patients, its unique mechanism of action has sparked ongoing research into its potential against a variety of other viral threats, including smallpox and HPV.
Cidofovir, marketed as Vistide, represents a significant development in antiviral therapy. First approved by the FDA in 1996, the drug functions by utilizing its active metabolite, cidofovir diphosphate, to selectively inhibit viral DNA polymerases. By incorporating itself into viral DNA, the medication effectively halts viral synthesis during reproduction. This process is notably precise, as the drug's inhibitory effect on human polymerases is 8 to 600 times weaker than its impact on viral targets, providing a degree of therapeutic selectivity.
The drug's primary clinical indication remains cytomegalovirus retinitis, a serious eye infection. However, its broad-spectrum potential has led to extensive investigation. It has shown in vitro activity against human poxviruses, including smallpox, and is considered a potential emergency measure for bioterrorism scenarios. Researchers have also explored its use for conditions like progressive multifocal leukoencephalopathy, papillomatosis, and aciclovir-resistant HSV infections, though results in controlled studies have been mixed. Furthermore, its ability to suppress FGF2 has even prompted interest in its potential as an antitumor agent.
Clinical administration of cidofovir is complex due to its significant nephrotoxicity, or kidney damage, which serves as the major dose-limiting side effect. To mitigate this risk, patients must receive the drug alongside probenecid, which inhibits organic anion transport in the kidney's proximal tubule epithelial cells. Additionally, clinicians mandate the administration of one liter of normal saline with every dose to ensure proper hydration. Because of these interactions, patients must avoid other nephrotoxic agents and drugs that interfere with probenecid, such as paracetamol or aciclovir, highlighting the necessity of careful medical oversight when utilizing this powerful antiviral tool.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Cidofovir
To cite this card, link to https://intellectplus.co.uk/app/technology-cidofovir.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Inventions · More in Technology · Latest · A–Z · All topics